- Home
- LENZ vs ATRO Comparison
LENZ vs ATRO Comparison
Compare LENZ & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- ATRO
- Stock Information
- Founded
- LENZ 2019
- ATRO 1968
- Country
- LENZ United States
- ATRO United States
- Employees
- LENZ N/A
- ATRO N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- ATRO Military/Government/Technical
- Sector
- LENZ Health Care
- ATRO Industrials
- Exchange
- LENZ Nasdaq
- ATRO Nasdaq
- Market Cap
- LENZ 819.1M
- ATRO 844.1M
- IPO Year
- LENZ 2021
- ATRO N/A
- Fundamental
- Price
- LENZ $29.16
- ATRO $31.85
- Analyst Decision
- LENZ Strong Buy
- ATRO Hold
- Analyst Count
- LENZ 5
- ATRO 1
- Target Price
- LENZ $41.80
- ATRO $21.00
- AVG Volume (30 Days)
- LENZ 180.2K
- ATRO 506.9K
- Earning Date
- LENZ 05-07-2025
- ATRO 05-06-2025
- Dividend Yield
- LENZ N/A
- ATRO N/A
- EPS Growth
- LENZ N/A
- ATRO N/A
- EPS
- LENZ N/A
- ATRO N/A
- Revenue
- LENZ N/A
- ATRO $816,288,000.00
- Revenue This Year
- LENZ N/A
- ATRO $8.44
- Revenue Next Year
- LENZ $534.98
- ATRO $6.33
- P/E Ratio
- LENZ N/A
- ATRO N/A
- Revenue Growth
- LENZ N/A
- ATRO 13.73
- 52 Week Low
- LENZ $14.42
- ATRO $14.13
- 52 Week High
- LENZ $38.93
- ATRO $32.01
- Technical
- Relative Strength Index (RSI)
- LENZ 57.21
- ATRO 72.14
- Support Level
- LENZ $28.14
- ATRO $30.75
- Resistance Level
- LENZ $30.09
- ATRO $31.90
- Average True Range (ATR)
- LENZ 1.51
- ATRO 0.92
- MACD
- LENZ 0.01
- ATRO 0.02
- Stochastic Oscillator
- LENZ 76.97
- ATRO 94.88
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About ATRO Astronics Corporation
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.